- Home
- DSM vs MASS Comparison
DSM vs MASS Comparison
Compare DSM & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- MASS
- Stock Information
- Founded
- DSM 1989
- MASS 2012
- Country
- DSM United States
- MASS United States
- Employees
- DSM N/A
- MASS N/A
- Industry
- DSM Investment Managers
- MASS Medical/Dental Instruments
- Sector
- DSM Finance
- MASS Health Care
- Exchange
- DSM Nasdaq
- MASS Nasdaq
- Market Cap
- DSM 280.8M
- MASS 235.8M
- IPO Year
- DSM N/A
- MASS 2020
- Fundamental
- Price
- DSM $5.75
- MASS $5.44
- Analyst Decision
- DSM
- MASS Strong Buy
- Analyst Count
- DSM 0
- MASS 3
- Target Price
- DSM N/A
- MASS $8.00
- AVG Volume (30 Days)
- DSM 161.7K
- MASS 248.3K
- Earning Date
- DSM 01-01-0001
- MASS 08-05-2025
- Dividend Yield
- DSM 3.97%
- MASS N/A
- EPS Growth
- DSM N/A
- MASS N/A
- EPS
- DSM N/A
- MASS N/A
- Revenue
- DSM N/A
- MASS $65,560,000.00
- Revenue This Year
- DSM N/A
- MASS N/A
- Revenue Next Year
- DSM N/A
- MASS $21.68
- P/E Ratio
- DSM N/A
- MASS N/A
- Revenue Growth
- DSM N/A
- MASS 37.93
- 52 Week Low
- DSM $4.69
- MASS $1.81
- 52 Week High
- DSM $6.05
- MASS $8.06
- Technical
- Relative Strength Index (RSI)
- DSM 69.52
- MASS 32.11
- Support Level
- DSM $5.61
- MASS $5.32
- Resistance Level
- DSM $5.68
- MASS $6.32
- Average True Range (ATR)
- DSM 0.05
- MASS 0.31
- MACD
- DSM 0.01
- MASS -0.09
- Stochastic Oscillator
- DSM 100.00
- MASS 8.82
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.